The specific combination of Dylight®550 and anti-B7H3-scFv on B7H3/Dox@GNCs emitted green fluorescence, indicating that anti-B7H3-scFv was successfully attached to the surface of multifunctional gold nanocarriers, exhibited active targeting and specifically attached to the tumor cells, and subsequently internalized. This evidence concerns the gene CD276 and neoplasm.